Michael A. Schmid

Here below are the publications (3) participated by Michael A. Schmid along with Anna De Marco (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Broad sarbecovirus neutralization by a human monoclonal antibody

Nature, settembre 2021

2) Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Science, 20 ottobre 2022

3) Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

Science, 20 novembre 2020

Facts & figures

Michael A. Schmid has coordinated or participated in 4 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 12 elements tag cloud:

SARS-CoV-2 (3) anti-HBs (1) chronic infection (1) HBsAg (1) Hepatitis B virus (HBV) (1) Hepatitis delta virus (HDV) (1) human antibodies (1) human liver chimeric mice (1) human monoclonal antibody (1) monoclonal antibody (mAb) (1) neutralization (1) virus spread (1)

Michael A. Schmid has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

Science (2) Journal of Hepatology (1) Nature (1)

Michael A. Schmid has coordinated or participated in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 34 co-authors being active in Ticino:

Fabio Benigni (4) Davide Corti (4) Fabrizia Zatta (4) Elisabetta Cameroni (3) Dora Pinto (3) Stefano Jaconi (3) Anna De Marco (3) Katja Culap (2) Siro Bianchi (2) Chiara Silacci Fregni (2) Christian Saliba (2) Barbara Guarino (2) Jessica Bassi (1) Alessia Peter (1) Lucia Vincenzetti (1) Antonio Lanzavecchia (1) Roberta Marzi (1) Alessandro Ceschi (1) Martina Beltramello (1) Olivier Giannini (1) Isabella Giacchetto-Sasselli (1) Matteo Samuele Pizzuto (1) Nicola Sprugasci (1) Luca Piccoli (1) Katja Fink (1) Andrea Minola (1) Nadia Passini (1) Gloria Lombardo (1) Nicole Sprugasci (1) Paolo Ferrari (1) Istvan Bartha (1) Eneida Vetti (1) Martina Giurdanella (1) Matteo S. Pizzuto (1)

Michael A. Schmid has coordinated or participated in 4 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 17 most frequently used terms (excluding 20 not relevant terms) are here listed:

M.A.S. WORD CLOUD antibody (3) sars-cov (2) imprinted (1) omicron (1) sublineages (1) broadly (1) vir (1) controls (1) hepatitis (1) virus (1) hbsag (1) humanized (1) mice (1) ultrapotent (1) antibodies (1) sarbecovirus (1) monoclonal (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 20 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Il mondo delle startup

Michael A. Schmid has participated - as a whole - in 4 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Anna De Marco

1) Broad sarbecovirus neutralization by a human monoclonal antibody

2) Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

3) Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

Michael A. Schmid has participated - as a whole - in 4 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Anna De Marco